Stay updated with breaking news from Genetics Home. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sobi announces positive Phase 2 NOBLE results of pegcetacoplan in post-transplant recurrence of primary IC-MPGN and C3G 17 October, 2023 13:15 ...
/PRNewswire/ -- Sobi® and Apellis Pharmaceuticals, Inc. today announced that positive results from the Phase 2 NOBLE study investigating pegcetacoplan for the...
/PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced that...
STOCKHOLM, June 7, 2022 /PRNewswire/ -- Sobi (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the first patient has been dosed in the VALIANT phase 3 study investigating